Genenta Science SPA (GNTA)
3.237
+0.07
(+2.12%)
USD |
NASDAQ |
Jun 14, 16:00
Genenta Science Total Liabilities (Quarterly): 2.117M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.117M |
| June 30, 2023 | 2.089M |
| June 30, 2023 | 2.089M |
| December 31, 2022 | 2.466M |
| June 30, 2022 | 1.346M |
| Date | Value |
|---|---|
| June 30, 2022 | 1.346M |
| December 31, 2021 | 1.320M |
| June 30, 2021 | 2.011M |
| June 30, 2021 | 2.011M |
| December 31, 2020 | 2.891M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.320M
Minimum
Dec 2021
2.891M
Maximum
Dec 2020
1.969M
Average
2.050M
Median
Total Liabilities (Quarterly) Benchmarks
| Stevanato Group SPA | 952.81M |
| Lipocine Inc | 1.490M |
| Relmada Therapeutics Inc | 12.36M |
| FibroGen Inc | 552.02M |
| NovaBay Pharmaceuticals Inc | 5.197M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 24.70M |
| Shareholders Equity (Quarterly) | 22.59M |